Publications by authors named "Sheng-yong Yu"

Objective: To evaluate factors for predicting ventricular arrhythmia, the clinical effect of drugs on patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), and their long-term outcomes.

Methods: Six patients diagnosed with CPVT underwent a series of electrocardiograms and 24-hour Holter monitoring. β-blockers were recommended for all patients, while some patients were also prescribed propafenone and 1 patient underwent catheter-based renal sympathetic denervation (RDN).

View Article and Find Full Text PDF

Objective: To describe the clinical features of 6 patients with catecholaminergic polymorphic ventricular tachycardia.

Methods: Clinical data including signs and symptoms, electrocardiograms, Holter monitoring electrocardiograms and echocardiography was analyzed. Definite diagnosis was made based on the mutations of RYR2 and CASQ2.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Sheng-yong Yu"

  • - Sheng-yong Yu's research primarily focuses on catecholaminergic polymorphic ventricular tachycardia (CPVT), examining long-term outcomes and predictive factors associated with ventricular arrhythmia in affected patients.
  • - The studies involve detailed clinical assessments of patients, including electrocardiograms, Holter monitoring, and genetic testing (notably for mutations in RYR2 and CASQ2), to better understand the clinical features and therapeutic effectiveness.
  • - Findings indicate that β-blockers are the recommended treatment for CPVT, with additional therapies like propafenone and renal sympathetic denervation being explored for certain patients to improve long-term prognosis.